Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Made with Care
The SURPASS-4 clinical trial was a non-inferiority study comparing tirzepatide to insulin glargine where tirzepartide showed superior A1c and body weight reductions from baseline in adults with T2DM at increased CVD risk.[20] Also, tirzepatide reported a higher occurrence of individuals achieving an A1c below 7% compared to insulin glargine
Availability outside of China remains uncertain, though global expansion plans are underway
The GLP-1 weight loss plateau guide covers strategies for pushing past stalls, and the troubleshooting when peptides stop working addresses the most common causes and solutions
US$ 26.87
US$ 21.85
US$ 21.97
US$ 28.55
